BACKGROUND: The objective of this study was to evaluate changes in resting energy expenditure (REE), body composition and metabolic parameters, and to investigate predictors of the results in seriously obese patients after Roux-en-Y gastric bypass (RYGBP). METHODS: 31 patients (BMI 44.4 +/- 4.8 kg/m2; 27 female, 4 male; 37.3 +/- 11.1 y) were evaluated at baseline and 6 months after RYGBP. Weight, REE, waist circumference (WC), fat mass (FM) and fat-free mass (FFM), physical activity, food intake, fasting glucose (GLU), insulin (INS), HOMA-IR and lipid concentrations were measured. RESULTS: At 6 months, percentage of weight loss (%WL) was 29.0 +/- 4.4% and percentage of excess weight loss was (%EWL) 59.7 +/- 12.3%. FM loss corresponded to 77.1 +/- 12.2% of the weight loss. REE decreased from 33.4 +/- 4.1 to 30.1 +/- 2.6 kcal/kg FFM (P<0.05). Significant decreases (P<0.001) were observed in GLU, INS, HOMA-IR, LDL-cholesterol and triglycerides. %EWL was correlated with baseline INS (r=0.44; P=0.014), baseline HOMA (r=0.43; P=0.017), change in %FM (r=0.67; P<0.001) and change in WC (r=0.5; P<0.01). Decrease in REE/FFM (%) was positively correlated with baseline REE/FFM% (r=0.51; P<0.005) and change in %FM (r=0.69; P<0.001). Initial REE/FFM, baseline energy balance and FM change explain 90% of REE/FFM decrease. CONCLUSION: RYGBP was an effective procedure to induce significant weight loss, fat mass loss and improvement in metabolic parameters in the short term. Metabolic adaptation was not related to FFM wasting but to a higher baseline REE. Fasting hyperinsulinemia was the best single predictor of weight loss after RYGBP.
BACKGROUND: The objective of this study was to evaluate changes in resting energy expenditure (REE), body composition and metabolic parameters, and to investigate predictors of the results in seriously obesepatients after Roux-en-Y gastric bypass (RYGBP). METHODS: 31 patients (BMI 44.4 +/- 4.8 kg/m2; 27 female, 4 male; 37.3 +/- 11.1 y) were evaluated at baseline and 6 months after RYGBP. Weight, REE, waist circumference (WC), fat mass (FM) and fat-free mass (FFM), physical activity, food intake, fasting glucose (GLU), insulin (INS), HOMA-IR and lipid concentrations were measured. RESULTS: At 6 months, percentage of weight loss (%WL) was 29.0 +/- 4.4% and percentage of excess weight loss was (%EWL) 59.7 +/- 12.3%. FM loss corresponded to 77.1 +/- 12.2% of the weight loss. REE decreased from 33.4 +/- 4.1 to 30.1 +/- 2.6 kcal/kg FFM (P<0.05). Significant decreases (P<0.001) were observed in GLU, INS, HOMA-IR, LDL-cholesterol and triglycerides. %EWL was correlated with baseline INS (r=0.44; P=0.014), baseline HOMA (r=0.43; P=0.017), change in %FM (r=0.67; P<0.001) and change in WC (r=0.5; P<0.01). Decrease in REE/FFM (%) was positively correlated with baseline REE/FFM% (r=0.51; P<0.005) and change in %FM (r=0.69; P<0.001). Initial REE/FFM, baseline energy balance and FM change explain 90% of REE/FFM decrease. CONCLUSION: RYGBP was an effective procedure to induce significant weight loss, fat mass loss and improvement in metabolic parameters in the short term. Metabolic adaptation was not related to FFM wasting but to a higher baseline REE. Fasting hyperinsulinemia was the best single predictor of weight loss after RYGBP.
Authors: M L Klem; R R Wing; C C Chang; W Lang; M T McGuire; H J Sugerman; S L Hutchison; A L Makovich; J O Hill Journal: Int J Obes Relat Metab Disord Date: 2000-05
Authors: Sai Krupa Das; Susan B Roberts; Joseph J Kehayias; Jack Wang; L K George Hsu; Scott A Shikora; Edward Saltzman; Megan A McCrory Journal: Am J Physiol Endocrinol Metab Date: 2003-02-25 Impact factor: 4.310
Authors: Lindsey E Bocchieri-Ricciardi; Eunice Y Chen; Daniel Munoz; Sarah Fischer; Maureen Dymek-Valentine; John C Alverdy; Daniel le Grange Journal: Obes Surg Date: 2006-09 Impact factor: 4.129
Authors: M B Livingstone; A M Prentice; W A Coward; S M Ceesay; J J Strain; P G McKenna; G B Nevin; M E Barker; R J Hickey Journal: Am J Clin Nutr Date: 1990-07 Impact factor: 7.045
Authors: W G van Gemert; K R Westerterp; B A van Acker; A J Wagenmakers; D Halliday; J M Greve; P B Soeters Journal: Int J Obes Relat Metab Disord Date: 2000-06
Authors: Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: A S Gallo; M A Berducci; S Nijhawan; D F Nino; R C Broderick; C R Harnsberger; S Lazar; C Echon; H F Fuchs; F Alvarez; B J Sandler; G Jacobsen; S Horgan Journal: Surg Endosc Date: 2014-08-27 Impact factor: 4.584
Authors: Stanley Heshka; Thaisa Lemos; Nerys M Astbury; Elizabeth Widen; Lance Davidson; Bret H Goodpaster; James P DeLany; Gladys W Strain; Alfons Pomp; Anita P Courcoulas; Susan Lin; Isaiah Janumala; Wen Yu; Patrick Kang; John C Thornton; Dympna Gallagher Journal: Obes Surg Date: 2020-02 Impact factor: 4.129